S. Özlük Et Al. , "Antiviral drug resistance rates among patients with chronic hepatitis B infection," European Journal of Clinical and Experimental Medicine , vol.21, no.2, pp.283-288, 2023
Özlük, S. Et Al. 2023. Antiviral drug resistance rates among patients with chronic hepatitis B infection. European Journal of Clinical and Experimental Medicine , vol.21, no.2 , 283-288.
Özlük, S., Bayram, Y., Özkaçmaz, A., Parlak, M., Özdemir, A., & Aypak, C., (2023). Antiviral drug resistance rates among patients with chronic hepatitis B infection. European Journal of Clinical and Experimental Medicine , vol.21, no.2, 283-288.
Özlük, Suat Et Al. "Antiviral drug resistance rates among patients with chronic hepatitis B infection," European Journal of Clinical and Experimental Medicine , vol.21, no.2, 283-288, 2023
Özlük, Suat Et Al. "Antiviral drug resistance rates among patients with chronic hepatitis B infection." European Journal of Clinical and Experimental Medicine , vol.21, no.2, pp.283-288, 2023
Özlük, S. Et Al. (2023) . "Antiviral drug resistance rates among patients with chronic hepatitis B infection." European Journal of Clinical and Experimental Medicine , vol.21, no.2, pp.283-288.
@article{article, author={Suat Özlük Et Al. }, title={Antiviral drug resistance rates among patients with chronic hepatitis B infection}, journal={European Journal of Clinical and Experimental Medicine}, year=2023, pages={283-288} }